Long-term prognosis of patients with Brugada syndrome and an implanted cardioverter-defibrillator

被引:6
|
作者
Dores, Helder [1 ]
Santos, Katya Reis [2 ]
Adragao, Pedro [1 ]
Costa, Francisco Moscoso [1 ]
Santos, Pedro Galvao [1 ]
Carmo, Pedro [1 ]
Cavaco, Diogo [1 ]
Morgado, Francisco Bello [1 ]
Mendes, Miguel [1 ]
机构
[1] Hosp Santa Cruz, Ctr Hosp Lisboa Ocidental, Serv Cardiol, Carnaxide, Portugal
[2] Hosp Luz, Ctr Cardiovasc, Lisbon, Portugal
关键词
Brugada syndrome; Implantable cardioverter-defibrillator; Prognosis; Syncope; Sudden cardiac death; Appropriate shocks; ST-SEGMENT ELEVATION; BUNDLE-BRANCH BLOCK; SUDDEN CARDIAC DEATH; FOLLOW-UP; ELECTROCARDIOGRAPHIC PATTERN; RISK STRATIFICATION; INDIVIDUALS; PREVALENCE; THERAPY; DETERMINANTS;
D O I
10.1016/j.repc.2014.12.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Risk stratification of Brugada syndrome (BrS) remains controversial and recommendations for an implantable cardioverter-defibrillator (ICD) are not well established. The objective of this study was to assess the long-term prognosis of BrS patients with an ICD. Methods and Results: Of 55 consecutive patients with BrS assessed between April 2002 and October 2012, 36 (mean age 41.7 +/- 13.8 years; 81.8% male) underwent ICD implantation. Nineteen (52.8%) were asymptomatic, 11 (30.6%) had previous history of syncope (arrhythmic cause suspected in eight) and six (16.7%) had aborted sudden cardiac death (SCD). Spontaneous type 1 electrocardiographic (ECG) pattern was present in 25 (69.4%) patients and electrophysiological study (EPS), performed in 26 (72.2%), was positive in 22 (84.6%). During a mean follow-up of 74 +/- 40 months (>5 years in 72% of cases), seven (19.4%) patients had appropriate shocks (annual event rate 2.8%). These patients most frequently had aborted SCD (54.1% vs. 6.9%; p=0.008) and nonsustained ventricular tachycardia (57.1% vs. 10.3%; p=0.016) during follow-up. Spontaneous type 1 ECG pattern, syncope and positive EPS were not significantly associated with appropriate shocks. Multivariate analysis revealed that aborted SCD was an independent predictor of appropriate shocks (HR 8.07, 95% CI 1.58-41.2; p=0.012). ROC curve analysis demonstrated that aborted SCD had moderate discriminatory power to predict appropriate shocks (AUC 0.751), with sensitivity of 57% and specificity of 93%. In terms of ICD-related complications, eight (22.2%) patients had inappropriate shocks during the follow-up period, mainly due to sinus tachycardia (five patients); one patient had lead infection and another had a lead fracture. Conclusion: In this population of BrS patients with ICD, the long-term rate of appropriate shocks was 2.8%/year. Aborted SCD was associated with a higher risk of appropriate shocks, where as syncope and spontaneous type I ECG pattern did not predict this event. (C) 2014 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:394 / 401
页数:8
相关论文
共 50 条
  • [21] Implantable Cardioverter-Defibrillator Therapy in Brugada Syndrome A 20-Year Single-Center Experience
    Conte, Giulio
    Sieira, Juan
    Ciconte, Giuseppe
    de Asmundis, Carlo
    Chierchia, Gian-Battista
    Baltogiannis, Giannis
    Di Giovanni, Giacomo
    La Meir, Mark
    Wellens, Francis
    Czapla, Jens
    Wauters, Kristel
    Levinstein, Moises
    Saitoh, Yukio
    Irfan, Ghazala
    Julia, Justo
    Pappaert, Gudrun
    Brugada, Pedro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (09) : 879 - 888
  • [22] Long-term efficacy of catheter ablation for paroxysmal atrial fibrillation in patients with Brugada syndrome and an implantable cardioverter-defibrillator to prevent inappropriate shock therapy
    Kitamura, Takeshi
    Fukamizu, Seiji
    Kawamura, Iwanari
    Hojo, Rintaro
    Aoyama, Yuya
    Komiyama, Kota
    Nishizaki, Mitsuhiro
    Hiraoka, Masayasu
    Sakurada, Harumizu
    HEART RHYTHM, 2016, 13 (07) : 1455 - 1459
  • [23] Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome
    Sarkozy, Andrea
    Boussy, Tim
    Kourgiannides, Georgios
    Chierchia, Gian-Battista
    Richter, Sergio
    De Potter, Tom
    Geelen, Peter
    Wellens, Francis
    Spreeuwenberg, Marieke Dingena
    Brugada, Pedro
    EUROPEAN HEART JOURNAL, 2007, 28 (03) : 334 - 344
  • [24] The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital
    Anil-Martin Sinha
    Jens Bense
    Wolfgang Hohenforst-Schmidt
    Journal of Interventional Cardiac Electrophysiology, 2021, 62 : 401 - 407
  • [25] The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital
    Sinha, Anil-Martin
    Bense, Jens
    Hohenforst-Schmidt, Wolfgang
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2021, 62 (02) : 401 - 407
  • [26] Benefit of implantable cardioverter-defibrillator therapy after generator replacement in patients with Brugada syndrome
    Kim, Ju Youn
    Kim, Sung-Hwan
    Kim, Sung Su
    Lee, Ki Hong
    Park, Hyung-Wook
    Cho, Jeong-Gwan
    Uhm, Jae-Sun
    Joung, Boyoung
    Pak, Hui-Nam
    Lee, Moon-Hyoung
    Park, Seung-Jung
    On, Young Keun
    Kim, June Soo
    Lim, Hong Euy
    Shim, Jaemin
    Choi, Jong-Il
    Park, Sang Weon
    Kim, Young-Hoon
    Lee, Woo Seok
    Kim, Jun
    Nam, Gi-Byoung
    Choi, Kee-Joon
    Kim, You-Ho
    Oh, Yong-Seog
    Lee, Man-Young
    Rho, Tai-Ho
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 187 : 340 - 344
  • [27] Low disease prevalence and inappropriate implantable cardioverter defibrillator shock rate in Brugada syndrome: a nationwide study
    Holst, Anders Gaarsdal
    Jensen, Henrik Kjaerulf
    Eschen, Ole
    Henriksen, Finn Lund
    Kanters, Jorgen
    Bundgaard, Henning
    Svendsen, Jesper Hastrup
    Haunso, Stig
    Tfelt-Hansen, Jacob
    EUROPACE, 2012, 14 (07): : 1025 - 1029
  • [28] Implantable cardioverter defibrillator and catheter ablation in Brugada syndrome
    Pappone, Carlo
    Santinelli, Vincenzo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2017, 18 : e35 - e39
  • [29] Cardiac Sarcoidosis: Electrophysiological Outcomes on Long-Term Follow-Up and the Role of the Implantable Cardioverter-Defibrillator
    Mohsen, Amr
    Jimenez, Alejandro
    Hood, Robert E.
    Dickfeld, Timm
    Saliaris, Anastasios
    Shorofsky, Stephen
    Saba, Magdi M.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2014, 25 (02) : 171 - 176
  • [30] Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome -: A multicenter study
    Sacher, Frederic
    Probst, Vincent
    Iesaka, Yoshito
    Jacon, Peggy
    Laborderie, Julien
    Mizon-Gerard, Frederique
    Mabo, Philippe
    Reuter, Sylvain
    Lamaison, Dominique
    Takahashi, Yoshihide
    O'Neill, Mark D.
    Garrigue, Stephane
    Pierre, Bertrand
    Jais, Pierre
    Pasquie, Jean-Luc
    Hocini, Meleze
    Salvador-Mazenq, Michele
    Nogami, Akihiko
    Amiel, Alain
    Defaye, Pascal
    Bordachar, Pierre
    Boveda, Serge
    Maury, Philippe
    Klug, Didier
    Babuty, Dominique
    Haissaguerre, Michel
    Mansourati, Jacques
    Clementy, Jacques
    Le Marec, Herve
    CIRCULATION, 2006, 114 (22) : 2317 - 2324